Try our mobile app

Published: 2021-11-02 00:00:00 ET
<<<  go to VECO company page
HTTP/1.1 200 OK HTTP/1.1 200 OK X-Crawlera-Slave: 162.223.122.186:3128 X-Crawlera-Version: 1.60.1 accept-ranges: bytes content-type: text/html last-modified: Tue, 02 Nov 2021 20:12:14 GMT server: AmazonS3 x-amz-id-2: XqZWYAhxHEkREw6ygeuDM3gvQGD4RacC2J833lMf6iJ181hRTWk8wuAq0iivYMlaabi1juWAFmI= x-amz-meta-mode: 33188 x-amz-meta-s3cmd-attrs: uid:504/gname:fitrprnt/uname:fitrprnt/gid:504/mode:33184/mtime:1635883927/atime:1635883927/md5:b8fb147501c80aa36d0a785ff118f33f/ctime:1635883931 x-amz-replication-status: COMPLETED x-amz-request-id: YH9BZ0BPAXGHNF4J x-amz-version-id: Ayp9fjs..orUvDQhQszhLARkHnKqwerR x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-akamai-transformed: 9 21472 0 pmb=mTOE,2 expires: Fri, 07 Apr 2023 01:35:29 GMT cache-control: max-age=0, no-cache, no-store pragma: no-cache date: Fri, 07 Apr 2023 01:35:29 GMT vary: Accept-Encoding akamai-x-true-ttl: -1 strict-transport-security: max-age=31536000 ; includeSubDomains ; preload set-cookie: ak_bmsc=EEC693583227D0485A912979BEB15633~000000000000000000000000000000~YAAQlag8F+XlzlaHAQAAYbRaWRPBFXTDSmWoG0de2VuSIjIVmo6dR7CbkQmbE5lDVNsqNN2fXIt2B16dy0VrjDSo9P6Wes8JflivbjbdMq5HpDtNQyyOGC1gA5gTjtEQNjqWXykr06e1PSjAc3rK68PhEa0wiqWyumZCQufrwd4Z/rHBXVAc3umy+5PFuRX1oyXWC8gmNl4Nf+AH33oZ2/VW11oMIoHlVqCM0SFd7Xu5vBzJMNa54p+Twat1ZvVKuIjqajephbs16R7gD3ZW6ydflEClDuPu6jCSgVE0SlPdY8Ky9ZhKFQgile+aBUysEytu4pUqkz1oFtnghFBXg+iNDYRVj/mCRcHr80FAuClXyUKNon6uTxM06cXrxIcP65si//LEyaeK; Domain=.sec.gov; Path=/; Expires=Fri, 07 Apr 2023 03:35:28 GMT; Max-Age=7199; HttpOnly set-cookie: bm_mi=8C06856EFFB2538B2CCA1BE5C5B58A4C~YAAQlag8F+blzlaHAQAAYbRaWRPolqGudZLq8kW6ek5/BGpHMOsBC1M0oGkRzlFjib7xcqs5EMXdTSSlqQVIUoujul13Qvc7efLw4NXYDjk0pFRyWPK5j/7o+V5R4E5/6yaQpllPxx79NTaCJDasc/dTSQzS68HMzhJQLDUiGx9e5uqZ/UmG6XgtArPxzIY5CJ52wF+2mfysLHydFQUCJkswv9wFHg3QsWfm+H+rY0Nn8sIF3vH8Uz4QoT3eawg5td42L+BdQru2ETnKKVvhX9IP+DP8SRAGMvJ9lX0piLtlKLkNiaDp0yFtTlVJxxL30MMfU/8yyopS3Hv9eNHBhZZOM7uHjV7VEX2kCeAPS7St7L0P6/EzTunI/gv1tckVEHGMI/U/NOaAlMY6+PaXwQI=~1; Domain=.sec.gov; Path=/; Expires=Fri, 07 Apr 2023 01:35:29 GMT; Max-Age=0; Secure Transfer-Encoding: chunked Proxy-Connection: close Connection: close EX-99.1 2 veco-20211102xex99d1.htm EX-99.1

EXHIBIT 99.1

A picture containing drawing

Description generated with very high confidence

VEECO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS

Third Quarter 2021 Highlights:

Revenues of $150.2 million, compared with $112.1 million in the same period last year
GAAP net income of $9.0 million, or $0.17 per diluted share, compared with $0.6 million, or $0.01 per diluted share in the same period last year
Non-GAAP net income of $20.5 million, or $0.40 per diluted share, compared with $11.0 million, or $0.22 per diluted share in the same period last year

Plainview, N.Y., November 2, 2021 -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2021. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.  

U.S. Dollars in millions, except per share data

GAAP Results

 

Q3 '21

Q3 '20

Revenue

$

150.2

$

112.1

Net income (loss)

$

9.0

$

0.6

Diluted earnings (loss) per share

$

0.17

$

0.01

Non-GAAP Results

 

Q3 '21

Q3 '20

Net income (loss)

$

20.5

$

11.0

Operating income (loss)

$

24.3

$

14.1

Diluted earnings (loss) per share

$

0.40

$

0.22

“Veeco delivered solid year-on-year and sequential growth in the third quarter with revenue and EPS at the high end of our guidance range. Cash flow from operations was the highest in several years demonstrating the effectiveness of our transformation,” commented William J. Miller, Ph.D., Chief Executive Officer. “Record semiconductor sales were the primary driver of our performance with shipments of our Laser Annealing and EUV mask blank systems. 

“Once again, we are improving our outlook for 2021 and we are excited about the traction in our semiconductor business, which has been a focus of our transformation,” continued Dr. Miller.  “We expect to ship the first systems in the coming weeks from our new state-of-the-art San Jose semiconductor equipment manufacturing facility.”

1


Guidance and Outlook

The following guidance is provided for Veeco’s fourth quarter 2021:

Revenue is expected in the range of $140 million to $160 million
GAAP diluted earnings per share are expected in the range of $0.04 to $0.22
Non-GAAP diluted earnings per share are expected in the range of $0.27 to $0.45

Please refer to the tables at the end of this press release for further details.

Conference Call Information

A conference call reviewing these results has been scheduled for today, November 2, 2021 starting at 5:00pm ET. To join the call, dial 1-800-437-2398 (toll free) or 1-929-477-0577 and use passcode 3331305. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, the impact of the COVID-19 pandemic, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the Company’s operations and on those of our customers and suppliers; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:

Investors:Anthony Bencivenga (516) 252-1438abencivenga@veeco.com

Media:Kevin Long (516) 714-3978klong@veeco.com

2


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)
(unaudited)

Three months ended September 30,

Nine months ended September 30,

 

    

2021

    

2020

    

2021

    

2020

 

Net sales

 

$

150,246

 

$

112,078

 

$

430,305

 

$

315,216

Cost of sales

 

87,077

 

62,936

 

252,055

 

177,761

Gross profit

 

63,169

 

49,142

 

178,250

 

137,455

Operating expenses, net:

Research and development

 

21,999

 

19,129

 

66,397

 

57,577

Selling, general, and administrative

 

21,603

 

19,415

 

63,325

 

55,541

Amortization of intangible assets

 

2,976

 

3,831

 

9,305

 

11,502

Restructuring

 

 

 

 

1,097

Asset impairment

 

 

 

 

281

Other operating expense (income), net

 

175

 

(218)

 

138

 

(502)

Total operating expenses, net

 

46,753

 

42,157

 

139,165

 

125,496

Operating income (loss)

 

16,416

 

6,985

 

39,085

 

11,959

Interest expense, net

 

(7,012)

 

(6,194)

 

(20,221)

 

(16,673)

Loss on extinguishment of debt

(3,046)

Income (loss) before income taxes

 

9,404

 

791

 

18,864

 

(7,760)

Income tax expense (benefit)

 

411

 

211

 

1,029

 

530

Net income (loss)

 

$

8,993

 

$

580

 

$

17,835

 

$

(8,290)

Income (loss) per common share:

Basic

 

$

0.18

 

$

0.01

 

$

0.36

 

$

(0.17)

Diluted

 

$

0.17

 

$

0.01

 

$

0.33

 

$

(0.17)

Weighted average number of shares:

Basic

 

49,021

 

48,341

 

48,968

 

48,327

Diluted

 

53,849

 

49,174

 

53,606

 

48,327

3


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in thousands)

September 30,

December 31,

    

2021

    

2020

(unaudited)

Assets

Current assets:

Cash and cash equivalents

$

121,602

$

129,625

Restricted cash

 

629

 

658

Short-term investments

 

213,985

 

189,771

Accounts receivable, net

 

86,759

 

79,991

Contract assets

 

27,467

 

21,246

Inventories

 

170,835

 

145,906

Deferred cost of sales

 

635

 

433

Prepaid expenses and other current assets

 

31,592

 

19,301

Total current assets

 

653,504

 

586,931

Property, plant and equipment, net

 

93,851

 

65,271

Operating lease right-of-use assets

26,481

 

10,275

Intangible assets, net

 

36,880

 

46,185

Goodwill

 

181,943

 

181,943

Deferred income taxes

 

1,440

 

1,440

Other assets

 

3,709

 

6,019

Total assets

$

997,808

$

898,064

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$

48,749

$

33,656

Accrued expenses and other current liabilities

 

76,033

 

44,876

Customer deposits and deferred revenue

 

60,703

 

67,235

Income taxes payable

 

1,737

 

914

Total current liabilities

 

187,222

 

146,681

Deferred income taxes

 

5,228

 

5,240

Long-term debt

 

331,877

 

321,115

Long-term operating lease liabilities

30,325

 

6,305

Other liabilities

 

7,843

 

10,349

Total liabilities

 

562,495

 

489,690

Total stockholders’ equity

 

435,313

 

408,374

Total liabilities and stockholders’ equity

$

997,808

$

898,064

4


Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

Non-GAAP Adjustments

 

Share-Based

 

Three months ended September 30, 2021

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

 

Net sales

$

150,246

$

150,246

 

Gross profit

 

63,169

 

620

 

150

 

63,939

Gross margin

 

42.0

%

 

42.6

%

Operating expenses

 

46,753

 

(3,510)

(2,976)

(637)

39,630

Operating income (loss)

 

16,416

 

4,130

2,976

 

787

^

24,309

Net income (loss)

 

8,993

 

4,130

 

2,976

 

4,375

^

20,474

Income (loss) per common share:

Basic

$

0.18

$

0.42

Diluted

 

0.17

 

0.40

Weighted average number of shares:

Basic

 

49,021

 

49,021

Diluted (1)

 

53,849

 

51,679


^

- See table below for additional details.

(1)    - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, no incremental shares are added to the dilutive share count in periods in which the average stock price per share is below $18.46. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, incremental shares are added to the dilutive share count in periods in which the average stock price per share is above $13.98, and the Company is in a net income position. The average stock price for the three months ended September 30, 2021 was $22.24, and therefore 1.2 million shares were included in the non-GAAP diluted share count, and 3.3 million shares were included in the GAAP diluted share count related to the 2027 Notes.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

Three months ended September 30, 2021

    

Transition expenses related to San Jose expansion project

$

705

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

82

Subtotal

787

Non-cash interest expense

 

3,663

Non-GAAP tax adjustment *

 

(75)

Total Other

$

4,375


*

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

5


Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

Non-GAAP Adjustments

 

Share-based

Three months ended September 30, 2020

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

Net sales

$

112,078

$

112,078

Gross profit

 

49,142

 

389

 

288

 

49,819

Gross margin

 

43.8

%  

44.5

%

Operating expenses

 

42,157

 

(2,553)

(3,831)

(28)

35,745

Operating income (loss)

 

6,985

 

2,942

3,831

 

316

^

14,074

Net income (loss)

 

580

 

2,942

 

3,831

 

3,654

^

11,007

Income (loss) per common share:

Basic

$

0.01

$

0.23

Diluted

 

0.01

0.22

Weighted average number of shares:

Basic

 

48,341

48,341

Diluted

 

49,174

49,174


^

- See table below for additional details.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

Three months ended September 30, 2020

Release of inventory fair value step-up associated with the Ultratech purchase accounting

$

273

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

43

Subtotal

316

Non-cash interest expense

 

3,504

Non-GAAP tax adjustment *

 

(166)

Total Other

$

3,654


*

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

6


Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)

(in thousands)
(unaudited)

    

Three months ended

    

Three months ended

September 30, 2021

September 30, 2020

GAAP Net income (loss)

$

8,993

$

580

Share-based compensation

 

4,130

 

2,942

Amortization

 

2,976

 

3,831

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

 

273

Transition expenses related to San Jose expansion project

 

705

 

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

82

 

43

Interest (income) expense, net

 

7,012

 

6,194

Income tax expense (benefit)

 

411

 

211

Non-GAAP Operating income (loss)

$

24,309

$

14,074

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

7


Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in millions, except per share amounts)

(unaudited)

Non-GAAP Adjustments

 

Guidance for the three months ending

Share-based

 

December 31, 2021

GAAP

Compensation

Amortization

   Other    

Non-GAAP

 

Net sales

    

$

140

    

-

    

$

160

    

    

    

    

$

140

    

-

    

$

160

Gross profit

 

58

 

-

 

69

 

1

 

 

 

59

 

-

 

70

Gross margin

 

41%

-

 

43%

 

 

 

41%

-

 

43%

Operating expenses

48

 

-

 

50

(3)

(3)

(1)

41

 

-

 

43

Operating income (loss)

10

-

19

4

3

1

18

-

27

Net income (loss)

$

2

 

-

$

11

 

4

 

3

5

$

14

 

-

$

23

Income (loss) per diluted common share

$

0.04

 

-

$

0.22

 

  

 

  

 

  

$

0.27

 

-

$

0.45

Weighted average number of shares (1)

 

54

 

54

 

 

 

 

52

 

52


(1)    - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, no incremental shares are added to the dilutive share count in periods in which the average stock price per share is below $18.46. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, incremental shares are added to the dilutive share count in periods in which the average stock price per share is above $13.98, and the Company is in a net income position.

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)

(in millions)
(unaudited)

Guidance for the three months ending December 31, 2021

    

    

    

GAAP Net income (loss)

$

2

 

-

$

11

Share-based compensation

 

4

 

-

 

4

Amortization

 

3

 

-

 

3

Interest expense, net

 

7

 

-

 

7

Income tax expense (benefit)

1

-

1

Other

 

1

 

-

 

1

Non-GAAP Operating income (loss)

$

18

 

-

$

27

Note: Amounts may not calculate precisely due to rounding.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

8